San Diego Biotechnology Network

SDBN Feed: CalciMedica Announces Proposed Public Offering of Common Stock https://lnkd.in/gHzWQ54F LA JOLLA, Calif., Oct. 30, 2024 /PRNewswire/ — CalciMedica, Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (“CRAC”) channel inhibition therapies for acute and chronic… [...]

SDBN Feed: How Local Governments Can Lead the Way in Decarbonizing the U.S. https://lnkd.in/gUpFdF7S The success of the $1 trillion that was recently invested by the U.S. federal government to mitigate climate climate change through the Inflation Reduction Act (IRA) and the Bipartisan Infrastructure Law (BIL) largely depends on [...]

SDBN Feed: Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B https://lnkd.in/gncU_Rkr Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go after tough targets in Alzheimer’s [...]

SDBN Feed: Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases https://lnkd.in/gNHEEZQA LA JOLLA, Calif.–(BUSINESS WIRE)–As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unprecedented financial and care burden on overwhelmed [...]

SDBN Feed: Abzena Announces Major Expansion in Microbiology Laboratory Space in Support of Biologic Manufacturing https://lnkd.in/gBqeTcAi Increased Capacity, Efficiency, and Tools Help Abzena Ensure Higher Standards of Quality for Customers SAN DIEGO, Oct. 30, 2024 /PRNewswire/ — Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant [...]

SDBN Feed: ALZpath Proprietary pTau217 Antibody Named to TIME’S List of the Best Inventions of 2024 https://lnkd.in/gJkyXHcU CARLSBAD, Calif., Oct. 30, 2024 /PRNewswire/ — ALZpath, Inc., a leading developer of innovative diagnostic tools and solutions for Alzheimer’s disease and related dementias, today announced that it has been honored in TIME’s annual Best [...]

SDBN Feed: n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End https://lnkd.in/gfNQd5SN SAN DIEGO–(BUSINESS WIRE)– #ASO–n-Lorem, a nonprofit foundation, will assemble patients, physicians, partners and supporters today and tomorrow, Oct. 30 & 31, 2024, for its second annual Nano-rare Patient Colloquium. In this public meeting, n-Lorem will [...]

SDBN Feed: Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance https://lnkd.in/g69VmsD7 INGREZZA® (valbenazine) Third Quarter Net Product Sales of $613 Million Representing 26% Year-Over-Year Growth INGREZZA® (valbenazine) 2024 Net Product Sales Guidance Raised to $2.30 – $2.32 Billion Board Authorizes $300 Million Share Repurchase Plan SAN [...]

SDBN Feed: Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001) https://lnkd.in/giVXhbQv SAN DIEGO–(BUSINESS WIRE)–Alterome Therapeutics, Inc., a clinical stage biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, today announced the dosing of the first patient in AKTive-001, [...]

SDBN Feed: Biogen signs molecular glue deal, raises yearly projections https://lnkd.in/gxQXChit Is 2024 the year of molecular glues? Biogen on Tuesday became the latest company to partner on the increasingly popular subject, teaming up with private San Diego biotech Neomorph. Biogen will pay Neomorph an undisclosed [...]